Aspenpharmacare

What Aspenpharmacare does

Aspen Pharmacare Australia is a privately held pharmaceutical company headquartered in St Leonards, New South Wales, with a world-class TGA-, GMP-, and ISO-certified manufacturing facility in Dandenong, Victoria. The company operates three integrated business segments: (1) a Prescription Medicines portfolio covering anaesthetics, mental health, paediatrics, women's and men's health, dermatology, endocrinology, metabolic diseases, infectious diseases, ophthalmology, and analgesics; (2) a Consumer OTC business spanning women's health, digestive health, pain management, nasal and sinus care, skin care, heart health, specialty formula, and sleep health (including recognised brands such as Bio-Oil, Cartia, Coloxyl, Maltofer, Emla, and Circadin); and (3) Manufacturing Operations producing solid and liquid dosage forms and medical devices for both Aspen's own brands and external contract manufacturing partners. Together, the portfolio comprises more than 150 brands reaching Australia, New Zealand, and 13 Asia Pacific markets, with exports to over 25 countries.

The company employs approximately 600 staff across Australia and New Zealand, including scientists, engineers, manufacturing and packing operators, sales and marketing professionals, regulatory and quality assurance experts, supply chain, and corporate functions. Its go-to-market combines a field sales force targeting healthcare professionals through the HCP Resource Hub and Aspen Xpress mobile app, wholesale and pharmacy distribution across Australia and New Zealand, in-market teams and distributors in Southeast Asia, and a contract manufacturing offering at the Dandenong facility. A core business development engine in-licenses high-potential products, both established and emerging, and revitalises deprioritised brands from multinational pharmaceutical partners for commercialisation in Australia and New Zealand.

Revenue is generated across four streams: prescription medicine sales, OTC consumer product sales, contract manufacturing services, and licensing and distribution royalties. The company is a subsidiary of Aspen Asia Pacific Pty Ltd, which is part of the Aspen APAC Group controlled by Apple SG Bidco Pte. Ltd., a Singapore-registered private equity vehicle. Operations commenced in Australia in 2001 and expanded into New Zealand in 2003, with subsequent geographic expansion into Hong Kong, Malaysia, Philippines, Taiwan, and Vietnam. The company is positioned as a trusted partner to multinational pharmaceutical companies for product registration, manufacturing, commercialisation, distribution, and regulatory and pricing support across the ANZ and APAC region.

Name

Aspenpharmacare

Legal name

Aspen Pharmacare Australia Pty Ltd

Website

https://aspenpharmacare.com.au

Company type

Private

Founded year

2001

Operating status

Operating

Short description

Aspen Pharmacare Australia is a privately held, PE-backed pharmaceutical company operating a 150+ brand prescription and OTC portfolio across 13 Australia, New Zealand, and Asia Pacific markets, with a TGA- and GMP-certified manufacturing facility in Dandenong, Victoria, serving healthcare professionals, consumers, and multinational licensing partners.

Ownership category

akta.pro rank

Product category

Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Surgical and Medical Instrument Manufacturing (339112)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

OTC Medicines & Consumer Health Products Distribution (CRAOAHAB)

akta.pro secondary industries

Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA), Cold, Flu & Cough Remedies (HLAIADAB), Infectious Disease & Antimicrobials Pharmaceuticals (HLAIAAAG)

Keywords

• Prescription pharmaceuticals
• Consumer OTC medicines
• Pharmaceutical manufacturing
• Contract manufacturing services
• Therapeutic healthcare products

Headquarters

HQ city

St Leonards

HQ country

Australia

HQ region

Oceania

Offices8 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Prescription Medicines Sales: Revenue from sales of prescription medicines covering most disease states including anaesthetics, mental health, paediatric health, women's and men's health, dermatology, endocrinology, metabolic diseases, infectious diseases, ophthalmology, and analgesics.
2. Consumer OTC Products: Sales of over-the-counter consumer healthcare brands including women's health, digestive health, pain management, nasal and sinus care, skin care, heart health, specialty formula, and sleep health products. Many brands are household names and leaders in their categories.
3. Contract Manufacturing Services: Provides contract manufacturing services to external partners using the Dandenong facility's manufacturing capabilities for solids and liquids, serving both domestic Australian and international export markets.
4. Licensing and Distribution Partnerships: In-licensing high-potential products and expanding their market reach, working with partners on established or new brands that may be underleveraged or deprioritised within broader portfolios.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

Core offering

Aspen Pharmacare Australia develops, manufactures and commercialises a portfolio of more than 150 prescription and over-the-counter (OTC) pharmaceutical brands spanning a wide range of therapeutic areas, including anaesthetics, mental health, paediatrics, women's and men's health, dermatology, endocrinology, metabolic diseases, infectious diseases, ophthalmology and analgesics. The company operates a TGA, GMP and ISO licensed manufacturing facility in Dandenong, Victoria (one of the largest in Australia) that produces solid dosage forms, liquid dosage forms and medical devices for Australian and export markets, and also provides contract manufacturing services to third-party pharmaceutical companies.

Product overview

Aspen Pharmacare Australia operates as a pharmaceutical company with three distinct business segments: Prescription Medicines, Consumer OTC, and Manufacturing Operations. The Prescription Medicines segment encompasses an extensive portfolio of over 150 prescription and OTC brands spanning multiple therapeutic areas including anaesthetics, mental health, paediatrics, women's/men's health, dermatology, endocrinology, metabolic diseases, infectious diseases, ophthalmology, and analgesics. The Consumer OTC segment includes iconic over-the-counter consumer healthcare brands organized by health categories: Women's Health (Fleurstat BVgel, Remifemin), Digestive Health (Coloxyl, Gastro-Stop, Maltofer, Ural), Pain Management (Dymadon, Sigmacort, Xylocaine), Nasal and Sinus Care (Flo, Logicin), Skin Care (Bio-Oil, Dermeze, Tricortone), Heart Health (Cartia), Specialty Formula (Nervoderm, Novalac), and Sleep Health (Circadin). The Manufacturing Operations segment runs a world-class GMP and TGA-licensed facility in Dandenong, Victoria, producing solid and liquid dosage forms as well as medical devices for both domestic and export markets. Additionally, the company provides the Aspen Xpress mobile app and HCP Resource Hub for healthcare professional engagement.

Differentiator

Problem solved

Functional benefit

Brands

• Bio-Oil: Skin care product
• Cartia
• Dermeze
• Emla
• Flo Nasal & Sinus Solutions
• Maltofer
• Circadin
• Xal-Ease
• Novalac
• Imigran Migraine
• Zantac
• Tricortone
• Sigmacort
• Coloxyl
• Logicin
• Gastro-Stop
• Fleurstat BVgel
• Eze Allergy Nasal Spray
• Stingose
• Larri Oral Spray
• Remifemin
• Nervoderm
• Ural Cranberry
• Ural Powder
• Gout Shield

Products and services

• Prescription Medicines Portfolio Portfolio of prescription medicines covering therapeutic areas including anaesthetics (Xylocaine, Marcain, Naropin, Diprivan), mental health (Aropax, Zyban SR, Serenace, Lithicarb), paediatrics, women's and men's health (Ovestin, Estro-pess, Reandron), dermatology (Betnovate, Aristocort), endocrinology (Eltroxin, Oroxine, Eutroxsig), metabolic diseases (Lipitor, Moduretic), infectious diseases (Amoxil, Keflex, Zinnat), ophthalmology (Xalatan, Xalacom, Atropt, Chlorsig) and analgesics (Zaldiar, Dolased, Tracrium). Targeted at prescribers, pharmacists and hospitals.
• Consumer OTC Products - Women's Health Over-the-counter women's health consumer brands including Fleurstat BVgel for vaginal health and Remifemin for menopausal symptom support, sold via pharmacy and retail channels.
• Consumer OTC Products - Digestive Health Digestive health consumer brands including Coloxyl (stool softener), Gastro-Stop (anti-diarrheal), Gout Shield (uric acid support), Maltofer (iron supplement) and Ural products, sold via pharmacy and retail channels.
• Consumer OTC Products - Pain Management Pain management consumer brands including Dymadon (paracetamol), Sigmacort (hydrocortisone cream) and Xylocaine (lidocaine) preparations for topical analgesia, sold via pharmacy and retail channels.
• Consumer OTC Products - Nasal and Sinus Care Nasal and sinus care brands including Flo Nasal & Sinus Solutions (saline nasal spray) and Logicin (oxymetazoline nasal decongestant), sold via pharmacy and retail channels.
• Consumer OTC Products - Skin Care Skin care consumer brands including Bio-Oil (skincare oil for scars and stretch marks), Dermeze (dry skin treatment) and Tricortone (corticosteroid cream), sold via pharmacy and retail channels.
• Consumer OTC Products - Heart Health Heart health consumer brand Cartia (aspirin for cardiovascular protection), sold via pharmacy and retail channels.
• Consumer OTC Products - Specialty Formula Specialty formula products including Nervoderm (neuralgia support) and Novalac (specialty infant formula), sold via pharmacy and retail channels.
• Consumer OTC Products - Sleep Health Sleep health product Circadin (prolonged-release melatonin for primary insomnia in patients aged 55+), sold via pharmacy and retail channels.
• Solid Dosage Manufacturing Contract manufacturing of solid dosage forms including tablets and powders using dry blending and wet granulation methods, packaged in bottle packs, blister packs and sachets, performed at the TGA/GMP/ISO licensed Dandenong facility.
• Liquid Dosage Manufacturing Contract manufacturing of liquid dosage forms including suspensions, ointments and creams, packaged in bottles, tubes and bags, performed at the TGA/GMP/ISO licensed Dandenong facility.
• Medical Device Manufacturing Contract manufacturing of medical devices including the Xal-Ease device for glaucoma eye drop delivery, produced at the ISO Device-licensed Dandenong facility for domestic and export markets.
• Contract Manufacturing Services End-to-end contract manufacturing services provided to external pharmaceutical partners using the Dandenong facility's TGA/GMP/ISO licensed capabilities for solid and liquid dosage forms and medical devices, serving domestic Australian and international export markets across 25+ countries.
• Aspen Xpress App Mobile application for healthcare professionals providing access to product resources, starter packs ordering, CPD opportunities, educational content, downloadable HCP and patient resources, and rep locator functionality. Available on Google Play.
• HCP Resource Hub Online portal for healthcare professionals providing starter packs and clinical resources, continuing professional development (CPD) opportunities, educational articles and videos, and downloadable resources for Aspen prescription products.

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Licensing and Acquisition PartnerscoreOEM/ Whitelabel/ Licensing PartnerAspen specialises in in-licensing high-potential products, both established and emerging, and expanding their market reach within Australia and New Zealand. Partners benefit from expertise in launching new brands and ability to rejuvenate mature healthcare brands.
• Distribution PartnerscoreChannel Partner/ Reseller/ DistributorPartnerships for distributing Aspen products internationally, currently reaching over 25 countries through network of distributor partners in Europe, Asia Pacific, Middle East, and Indian Ocean region.
• Contract Manufacturing PartnerscoreStrategic or Co-development PartnerExternal partners utilise Aspen's world-class manufacturing facility in Dandenong for prescription and OTC medicines, and medical devices for domestic and export markets.
• OzHarvestminorOthersFood rescue charity partnership - volunteers involved in production of meals delivered to local charities across Australia. OzHarvest delivers practical support by rescuing quality surplus food and delivering it to charities.
• Fair Food NZminorOthersNew Zealand food rescue charity partnership - volunteers involved in food rescue efforts. Partnership fights food waste and strengthens food security in New Zealand communities.
• R U OK?minorOthersNational suicide prevention charity partnership supporting mental health awareness. Aspen runs annual week-long awareness campaign focusing on checking in with colleagues through wellness activities.
• Export PartnerscoreChannel Partner/ Reseller/ DistributorInternational pharmaceutical or OTC companies with established presence in new territories and capability to effectively market and distribute brands from Aspen Australia's product range.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• AFT Pharmaceuticals: AFT Pharmaceuticals is an Australia and New Zealand-focused specialty pharmaceutical company with a portfolio of prescription and OTC products across pain, allergy, and women's health. Most directly comparable to Aspen Australia given shared ANZ market focus, branded OTC/Rx mix, and similar scale.
• Mayne Pharma Group: Mayne Pharma is an Australian specialty pharmaceutical company offering branded and generic Rx products, with manufacturing capabilities and a focus on women's health and dermatology. Comparable to Aspen Australia through its branded Rx/OTC portfolio and ANZ-centric operations.
• Mundipharma Australia: Mundipharma operates across Australia and New Zealand with a portfolio of prescription medicines, OTC products, and consumer health brands. Similar mid-sized pharma presence in ANZ with comparable therapeutic area coverage and partnership-based business model.

Broad incumbents

• Bayer Australia: Bayer Australia is part of the global Bayer Group with a broad portfolio spanning prescription pharmaceuticals, OTC consumer health, and crop science. Overlaps with Aspen Australia in OTC categories and prescription medicines but operates as part of a much larger multinational portfolio.
• GlaxoSmithKline Australia: GSK Australia is the Australian subsidiary of GlaxoSmithKline, a global pharmaceutical major with significant prescription and consumer health (OTC) operations in Australia. Competes across multiple therapeutic areas where Aspen Australia operates but with substantially greater scale and global R&D backing.
• Johnson & Johnson Innovative Medicine Australia: Johnson & Johnson operates across pharmaceuticals, medical devices, and consumer health in Australia. Overlaps with Aspen Australia in consumer health categories and prescription medicines but as part of a much broader and more diversified global portfolio.
• Pfizer Australia: Pfizer Australia is a major multinational pharmaceutical company with extensive prescription and OTC operations in Australia. Competes with Aspen Australia across multiple therapeutic areas including infectious diseases, ophthalmology, and OTC products, but at much larger scale and with proprietary R&D pipeline.
• Sanofi Australia: Sanofi Australia operates a broad portfolio of prescription medicines, vaccines, and consumer health products. Overlaps with Aspen Australia across OTC categories (allergy, digestive, pain) and select Rx therapeutic areas, but with significantly larger scale and global R&D investment.
• AstraZeneca Australia: AstraZeneca Australia is a major multinational pharmaceutical company with strong respiratory, cardiovascular, and oncology franchises. Comparable to Aspen Australia as a prescription medicine operator in Australia but with substantially larger scale and innovation-led portfolio.

Regional players

• Cipla Australia: Cipla Australia is the Australian subsidiary of Indian pharmaceutical major Cipla, focused on generic and specialty pharmaceutical products. Comparable through ANZ pharmaceutical distribution and manufacturing capabilities but with primary focus on generic rather than branded products.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/aspen-pharma

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aspenpharmacare